Microbicide Trials Network

MTN-017

The first Phase II trial of a rectal microbicide, MTN-017 is designed to evaluate the rectal safety, drug absorption and acceptability of a reduced glycerin formulation of tenofovir gel, as well as oral Truvada, among men who have sex with men and transgender women at several international sites.
 
See
  
02-October-2013
  
02-October-2013 
  
02-October-2013
  
25-March-2014
 
See Also
9-January-2013
      
3-April-2013
  
17-May-2012
  
5-March-2012